Private Equity News
Most Popular Private Equity Story
Talecris backers design a $1 billion IPO
Two big private equity firms appear to be behind the decision to push a $1 billion IPO for Talecris Biotherapeutics. Talecris uses plasma to make new therapies for chronic illness. Cerberus Capital Read more...
Latest Headlines
- October 6, 2010
- February 7, 2008
- July 30, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
